Our data demonstrate that breast cancer-specific mutants of CK1ε act as loss of function in the Wnt/β-catenin pathway but activate the Wnt/Rac1/JNK and Wnt/Ca2+ pathways. This evidence concerns the gene RAC1 and breast carcinoma.